Intrathecal baclofen for severe spasticity

G J Hankey, E G Stewart-Wynne, D Perlman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally-administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to antispasticity agents administered by mouth.

Original languageEnglish
Pages (from-to)465-6
Number of pages2
JournalThe Medical journal of Australia
Volume145
Issue number9
Publication statusPublished - 3 Nov 1986

Fingerprint

Baclofen
Spastic Paraparesis
Drug Delivery Systems
Multiple Sclerosis
Mouth
Therapeutics

Cite this

Hankey, G. J., Stewart-Wynne, E. G., & Perlman, D. (1986). Intrathecal baclofen for severe spasticity. The Medical journal of Australia, 145(9), 465-6.
Hankey, G J ; Stewart-Wynne, E G ; Perlman, D. / Intrathecal baclofen for severe spasticity. In: The Medical journal of Australia. 1986 ; Vol. 145, No. 9. pp. 465-6.
@article{0335680970584f10a3c8d97985150a74,
title = "Intrathecal baclofen for severe spasticity",
abstract = "The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally-administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to antispasticity agents administered by mouth.",
keywords = "Adult, Baclofen/administration & dosage, Catheters, Indwelling, Female, Humans, Injections, Spinal, Multiple Sclerosis/complications, Muscle Spasticity/drug therapy",
author = "Hankey, {G J} and Stewart-Wynne, {E G} and D Perlman",
year = "1986",
month = "11",
day = "3",
language = "English",
volume = "145",
pages = "465--6",
journal = "Medical Journal Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Co. Ltd",
number = "9",

}

Hankey, GJ, Stewart-Wynne, EG & Perlman, D 1986, 'Intrathecal baclofen for severe spasticity' The Medical journal of Australia, vol. 145, no. 9, pp. 465-6.

Intrathecal baclofen for severe spasticity. / Hankey, G J; Stewart-Wynne, E G; Perlman, D.

In: The Medical journal of Australia, Vol. 145, No. 9, 03.11.1986, p. 465-6.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intrathecal baclofen for severe spasticity

AU - Hankey, G J

AU - Stewart-Wynne, E G

AU - Perlman, D

PY - 1986/11/3

Y1 - 1986/11/3

N2 - The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally-administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to antispasticity agents administered by mouth.

AB - The intrathecal administration of baclofen by way of an implanted subcutaneous drug delivery system is described in a patient with a severe spastic paraparesis due to multiple sclerosis. Intrathecally-administered baclofen is proposed as another therapeutic dimension and adjunct to physical therapy in the management of patients with severe spasticity that is unresponsive to antispasticity agents administered by mouth.

KW - Adult

KW - Baclofen/administration & dosage

KW - Catheters, Indwelling

KW - Female

KW - Humans

KW - Injections, Spinal

KW - Multiple Sclerosis/complications

KW - Muscle Spasticity/drug therapy

M3 - Article

VL - 145

SP - 465

EP - 466

JO - Medical Journal Australia

JF - Medical Journal Australia

SN - 0025-729X

IS - 9

ER -

Hankey GJ, Stewart-Wynne EG, Perlman D. Intrathecal baclofen for severe spasticity. The Medical journal of Australia. 1986 Nov 3;145(9):465-6.